Filing Details
Editas Medicine, Inc. (NASDAQ:EDIT) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
8k filedNASDAQ:EDIT
Editas Medicine, Inc. (EDIT) Reports Material Event to SEC
Editas Medicine, Inc. (NASDAQ:EDIT) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
At publication ·
What changed
Editas Medicine, Inc. (NASDAQ:EDIT) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Editas Medicine filed a Form 8-K on October 8, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $2.84 with a market capitalization of $217.7 million as of the filing date.
- Material events reported in 8-K filings can include leadership changes, acquisitions, asset sales, or financial guidance changes.
Market Context
Editas Medicine, Inc.'s stock currently trades at $2.84 with a market capitalization of $217.7M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Editas Medicine, Inc.'s stock.
All SEC filings for Editas Medicine, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View EDIT Stock Page
Frequently Asked Questions
Where can I read EDIT's SEC filings?
Browse all filings on our EDIT SEC filings page.
What types of SEC filings does Editas Medicine, Inc. file?
Public companies like Editas Medicine, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.